Enhanced Treatment and Prevention of Alzheimer's Disease
Legal Citation
Summary of the Inventive Concept
A comprehensive approach to treating and preventing Alzheimer's disease, incorporating cognitive training, genetic testing, and neuroprotective agents, while leveraging the benefits of aluminum salts in a pharmaceutical formulation.
Background and Problem Solved
The original patent disclosed a method for treating mild cognitive impairment using an aluminum salt. However, it had limitations in terms of patient selection, cognitive training, and prevention of β-amyloid deposition. The new inventive concept addresses these limitations by introducing a holistic approach to Alzheimer's disease treatment and prevention.
Detailed Description of the Inventive Concept
The new inventive concept comprises four main components: 1) a pharmaceutical formulation containing an aluminum salt in an amount from about 1.0 mg to about 5.0 mg, 2) a cognitive training program tailored to the patient's individual cognitive abilities, 3) a genetic test to identify the patient's risk profile for Alzheimer's disease, and 4) a neuroprotective agent selected from vitamin D, omega-3 fatty acids, and antioxidants. The combination of these components provides a comprehensive approach to treating and preventing Alzheimer's disease.
Novelty and Inventive Step
The new inventive concept introduces the novel combination of cognitive training, genetic testing, and neuroprotective agents with aluminum salts, which is not obvious from the original patent. The integration of these components provides a synergistic effect, enhancing the treatment and prevention of Alzheimer's disease.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include varying the type and amount of neuroprotective agents, incorporating additional cognitive training methods, or using different genetic tests to identify risk profiles. These variations would ensure broad conceptual coverage and adaptability to different patient populations.
Potential Commercial Applications and Market
The enhanced treatment and prevention of Alzheimer's disease has significant commercial potential in the pharmaceutical and healthcare industries. The target market includes patients diagnosed with Alzheimer's disease, mild cognitive impairment, or those at risk of developing the disease. The inventive concept could be marketed as a comprehensive treatment package, including the pharmaceutical formulation, cognitive training program, genetic testing, and neuroprotective agents.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Neurodegenerative disease treatment, specifically Alzheimer's disease management and pharmaceutical interventions for cognitive impairment
Person of Ordinary Skill (PHOSITA) Profile
A medical researcher or neuropharmacologist with expertise in Alzheimer's disease treatment, possessing knowledge of pharmaceutical formulations, cognitive assessment techniques, and neurodegenerative disease progression
Obviousness Rationale
A person of ordinary skill would recognize that expanding the treatment approach for Alzheimer's disease by incorporating additional diagnostic and preventative measures is a logical extension of existing therapeutic strategies. The PTD builds upon the source patent's foundational approach of using aluminum salts by introducing complementary interventions that are well-known in the field of neurodegenerative disease management. These additional components represent predictable variations that would be obvious to a skilled practitioner seeking to optimize Alzheimer's disease treatment.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,568 |
|---|---|
| Title | Treatment and prevention of Alzheimer's disease (AD) |
| Assignee(s) | Advantage Therapeutics, Inc. |